Abstract:Importance: The prevalence of obesity in patients older than 65 years is increasing. A substantial number of beneficiaries covered by Medicare meet eligibility criteria for bariatric procedures. Objective: To assess the comparative effectiveness and safety of bariatric procedures in the Medicare-eligible population. Evidence review: This systematic review was conducted according to the PRISMA guidelines. Articles were identified through searches of PubMed, Embase, CINAHL, PsycINFO, Cochrane Central Trials Registry, Cochrane Database of Systematic Reviews, and scientific information packages from manufacturers, ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform, and US Food and Drug Administration drugs and devices portals from January 1, 2000, to June 31, 2017. Randomized and nonrandomized comparative studies that evaluated bariatric procedures in the Medicare-eligible population were eligible. Six researchers extracted data on design, interventions, outcomes, and study quality. Findings were synthesized qualitatively; a planned meta-analysis was not undertaken owing to clinical heterogeneity. Findings: A total of 11 455 citations were screened for eligibility. Of those, 16 met the eligibility criteria. Compared with no surgery or conventional weight-loss treatment, bariatric surgery results in greater weight loss. Overall mortality after 30 days is lower among bariatric patients (hazard ratio, HR, 0.50; 95% CI, 0.31-0.79, in the study with the longest follow-up of 5.9 years), although, based on 1 study, mortality within 30 days of surgery was higher than in nonsurgically treated controls (1.55% vs 0.53%; P < .001). Bariatric surgery is associated with lower risk of cardiovascular disease (HR, 0.59; 95% CI, 0.44-0.79 in the largest study comparison) and with improvements in respiratory, musculoskeletal, metabolic, and renal outcomes (increase in estimated glomerular filtration rate, 9.84; 95% CI, 8.05-11.62 mL/min/1.73m2). Compared with sleeve gastrectomy (SG) and adjustable gastric banding (AGB), Roux-en-Y gastric bypass (RYGB) appears to be associated with greater weight loss (percent excess weight loss, 23.8% [95% CI, 16.2%-31.4%] at the longest follow-up of 4 years) but the 3 procedures have similar associations with most non-weight loss outcomes. Overall postoperative complications are not statistically significantly different between RYGB and SG, although major and/or serious complications are more common after RYGB. However, these associations are susceptible to at least moderate risk of confounding, selection, or measurement biases. Conclusions and relevance: In the Medicare population, there is low to moderate strength of evidence that bariatric surgery as a weight loss treatment improves non-weight loss outcomes. Well-designed comparative studies are needed to credibly determine the treatment effects for bariatric procedures in this patient population.

Primary Versus Revisional Bariatric and Metabolic Surgery in Patients with a Body Mass Index ≥ 50 kg/m2—90-Day Outcomes and Risk of Perioperative Mortality

Open to Laparoscopic to Robotic

The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review

Outcome comparison between primary and revisional bariatric surgery: A propensity-matched analysis

BMI ≥ 70: A Multi-Center Institutional Experience of the Safety and Efficacy of Metabolic and Bariatric Surgery Intervention

Revisional Bariatric Surgery due to Complications: Indications and Outcomes

Robotic bariatric surgery reduces morbidity for revisional gastric bypass when compared to laparoscopic: outcome of 8-year MBSAQIP analysis of over 40,000 cases

Revision of restrictive bariatric procedures in elderly patients: results at a 5-year follow-up

Evaluating Safety and Durability of Adolescent Metabolic and Bariatric Surgery

A Comprehensive Guide to Unraveling the Complexities and Solutions of Revisional Bariatric Procedures

Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up

Medium to long-term outcomes of bariatric surgery in older adults with super obesity

Future Prospects of Metabolic and Bariatric Surgery: A Comprehensive Review

Primary versus Revisional One Anastomosis Gastric Bypass - Outcomes of patients with at least eight-year follow-up

Associations Between Body Mass and Revision Surgical Outcomes in Adult Scoliosis.

Short- and long-term mortality after bariatric surgery: A systematic review and meta-analysis

Current Status of Robot-Assisted Revisional Bariatric Surgery

30-day morbidity and mortality of revisional bariatric surgery - An international multi-centre collaborative (BROAD) study

Weighing the outcomes: the role of BMI in complex robotic esophageal and hepatobiliary operations

Comparative Effectiveness and Safety of Bariatric Procedures in Medicare-Eligible Patients: A Systematic Review

Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options